Key Laboratory of Drug Quality Control of Hebei Province, College of Pharmaceutical Sciences, Hebei University, Baoding 071002, China.
Key Laboratory of Drug Quality Control of Hebei Province, College of Pharmaceutical Sciences, Hebei University, Baoding 071002, China.
Bioorg Med Chem Lett. 2020 Mar 15;30(6):126985. doi: 10.1016/j.bmcl.2020.126985. Epub 2020 Jan 24.
A series of new 4-arylthiazole-2-amine derivatives as acetylcholinesterase inhibitors (AChEIs) were designed and synthesized, Furthermore, their inhibitory activities against acetylcholinesterase in vitro were tested by Ellman spectrophotometry, and the results of inhibitory activity test showed that most of them had a certain acetylcholinesterase inhibitory activity in vitro. Moreover, the IC value of compound 4f was to 0.66 μM, which was higher than that of Rivastigmine and Huperzine-A as reference compounds, and it had a weak inhibitory effect on butyrylcholinesterase. The potential binding mode of compound 4f with AChE was investigated by the molecular docking, and the results showed that 4f was strongly bound up with AChE with the optimal conformation, in addition, their binding energy reached -11.27 Kcal*mol. At last, in silico molecular property of the synthesized compounds were predicted by using Molinspiration online servers. It can be concluded that the lead AChEIs compound 4f presented satisfactory drug-like characteristics.
一系列新型的 4-芳基噻唑-2-胺衍生物作为乙酰胆碱酯酶抑制剂(AChEIs)被设计和合成。此外,它们对体外乙酰胆碱酯酶的抑制活性通过 Ellman 分光光度法进行了测试,抑制活性测试的结果表明,它们中的大多数在体外具有一定的乙酰胆碱酯酶抑制活性。此外,化合物 4f 的 IC 值为 0.66 μM,高于作为参考化合物的 Rivastigmine 和 Huperzine-A,并且对丁酰胆碱酯酶具有较弱的抑制作用。通过分子对接研究了化合物 4f 与 AChE 的潜在结合模式,结果表明,4f 与 AChE 具有很强的结合能力,具有最佳构象,此外,它们的结合能达到-11.27 Kcal*mol。最后,通过使用 Molinspiration 在线服务器对合成化合物的计算分子特性进行了预测。可以得出结论,先导 AChEIs 化合物 4f 表现出令人满意的类药性特征。